Cite
HARVARD Citation
Tilanus-Linthorst, M. et al. (2021). FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. European journal of surgical oncology. 47 (2), pp. e19-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tilanus-Linthorst, M. et al. (2021). FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. European journal of surgical oncology. 47 (2), pp. e19-. [Online].